Technology integration partner SecureCell delivers proven performance, versatility, and simplicity
DELFT — (June 22, 2014) – Applikon and SecureCell have signed an agreement for the worldwide marketing and sales of Advanced Process Information Management Software developed by SecureCell. The software allows the user to monitor and control bioprocesses and offers an extensive toolbox for analyzing process data cross platforms. Process information is generated based on data from different brands of bioreactors and a wide range of different cultivation volumes.
The software includes functionality for Design of Experiments, Reactor Planning, Media Preparation and Tracking, Parallel Processing, SCADA, Data Mining and Batch Reporting. The combination of the software with the broad range of Applikon Bioreactor Systems offers the user a unique system for validatable fast track development and basic research.
“The ever increasing amount of process data generated by more sensors in smaller parallel bioreactor systems needs advanced software to turn this data into useful information. With the SecureCell software we can offer a new dimension in data processing. Data management and data analysis is key for the future of R&D and process development in pharmaceutical industry. With this new software we are again leading the way in bioprocessing” said Erik Kakes, vice president of sales, Applikon Biotechnology.
“Applikon and SecureCell have a shared vision of the future of data management systems and we look forward to create solutions that integrate Applikon Bioreactors with our advanced software that has been developed over the past years in close cooperation with large pharmaceutical companies,” said Carlo Andretta, CEO of SecureCell.
About Applikon Biotechnology
Applikon Biotechnology BV (Delft, Netherlands) is a privately owned leading supplier of bioreactor systems for the pharmaceutical and the biotechnological market. Since 1974 we specialize in novel technologies in cultivation systems, measurement and control for the biopharmaceutical industry. In the past 40 years, Applikon Biotechnology has built up a broad portfolio of unique bioprocessing devices for both cell culture and microbial cultivation, and this has considerably set us apart from the competition. We are definitely a step ahead.
To learn more about Applikon Biotechnology, visit www.applikon-biotechnology.com
About SecureCell
To learn more about SecureCell, visit www.securecell.ch